Nonetheless, the impact of anti‐SSA on overall survival (OS) and progression‐free survival (PFS) in SSc remains unclear, partly due to the lack of longitudinal observation and potential overlap with other disease‐specific Abs. This evidence concerns the gene RO60 and systemic sclerosis.